Chimeric Therapeutics Limited (CHMMF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -20.71 Million AUD | 15.88% |
| 2023 | -24.63 Million AUD | -63.2% |
| 2022 | -15.09 Million AUD | 0.1% |
| 2021 | -15.1 Million AUD | -23502.3% |
| 2020 | -64.01 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -9.21 Million AUD | -1148.65% |
| 2024 Q4 | -16.77 Million AUD | 0.0% |
| 2024 Q1 | 878.58 Thousand AUD | 105.92% |
| 2024 FY | -20.71 Million AUD | 15.88% |
| 2023 Q1 | -5.82 Million AUD | 25.75% |
| 2023 FY | -24.63 Million AUD | -63.2% |
| 2023 Q4 | -14.82 Million AUD | -122.44% |
| 2023 Q3 | -6.66 Million AUD | 54.52% |
| 2023 Q2 | -14.65 Million AUD | -151.68% |
| 2022 Q4 | -7.84 Million AUD | -211.98% |
| 2022 FY | -15.09 Million AUD | 0.1% |
| 2022 Q3 | -2.51 Million AUD | 73.1% |
| 2022 Q2 | -9.34 Million AUD | -95.84% |
| 2022 Q1 | -4.77 Million AUD | 57.79% |
| 2021 Q2 | -3.54 Million AUD | -96.64% |
| 2021 FY | -15.1 Million AUD | -23502.3% |
| 2021 Q4 | -11.3 Million AUD | -101.08% |
| 2021 Q3 | -5.62 Million AUD | -58.69% |
| 2021 Q1 | -1.8 Million AUD | 0.0% |
| 2020 FY | -64.01 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 71.138% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 521.567% |
| SQZ Biotechnologies Company | -75.82 Million USD | 72.675% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -16.093% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 125.313% |
| Mesoblast Limited | -84.14 Million USD | 75.377% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -1248.863% |
| Genus plc | 6.4 Million USD | 423.738% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 312.669% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -2124.57% |
| Marizyme, Inc. | -34.08 Million USD | 39.216% |
| ContraFect Corporation | -56.88 Million USD | 63.58% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -148.134% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -354.895% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -1377.841% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -626.86% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -653.196% |
| MultiCell Technologies, Inc. | -722.81 USD | -2866379.434% |
| Accustem Sciences Inc. | -3.74 Million USD | -453.04% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 64.877% |
| EV Biologics, Inc. | -483.06 Thousand USD | -4189.139% |
| Q BioMed Inc. | -3.44 Million USD | -501.321% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 685.288% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -5218.479% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -688.545% |
| Biomind Labs Inc. | -1 Million USD | -1952.213% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | -324.613% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -211.66% |
| Skye Bioscience, Inc. | -13.67 Million USD | -51.547% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -943.011% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -69074.679% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -310.73% |
| IMV Inc. | -38.67 Million USD | 46.423% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -30.558% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -972.084% |
| GB Sciences, Inc. | -1.42 Million USD | -1358.576% |
| Alpha Cognition Inc. | -9.7 Million USD | -113.477% |
| HST Global, Inc. | -140.9 Thousand USD | -14604.167% |
| CSL Limited | 3.7 Billion USD | 100.56% |
| Halberd Corporation | -75.05 Thousand USD | -27507.195% |
| Enzolytics Inc. | -2.14 Million USD | -864.222% |
| Resverlogix Corp. | -12.74 Million USD | -62.516% |
| Affymax, Inc. | -15.04 Million USD | -37.706% |
| SYBLEU INC | -149.18 Thousand USD | -13788.725% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -553.959% |
| argenx SE | -425.04 Million USD | 95.125% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 62.673% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -1884.598% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -1211.877% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -508.497% |
| AVAX Technologies, Inc. | 6.69 Million USD | 409.571% |
| Zenith Capital Corp. | -8.94 Million USD | -131.681% |
| Genscript Biotech Corporation | -415.79 Million USD | 95.017% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -118832.323% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -743.85% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -11980.494% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 62.31% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -614.147% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -2005.496% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -1011.324% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -1549.618% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -933.502% |
| BioStem Technologies, Inc. | -7.77 Million USD | -166.349% |
| ONE Bio Corp. | 13.68 Million USD | 251.439% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -11316.481% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -1451.499% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -1741.861% |
| Agentix Corp. | -1.37 Million USD | -1410.414% |
| LadRx Corporation | -3.82 Million USD | -441.873% |
| Cell Source, Inc. | -4.32 Million USD | -379.018% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -4886.822% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -2916.115% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -2916.115% |
| NovAccess Global Inc. | -2.46 Million USD | -739.936% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -609.697% |
| Itoco Inc. | -919.14 Thousand USD | -2154.194% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -388.843% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -1751.582% |
| Kadimastem Ltd | -3.04 Million USD | -581.497% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -7816.371% |
| CytoDyn Inc. | -18.05 Million USD | -14.737% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -82217.044% |
| Mobile Lads Corp. | -554.55 Thousand USD | -3636.219% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -9314.48% |
| Qrons Inc. | -643.67 Thousand USD | -3118.882% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -3568.914% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -829.163% |
| Rebus Holdings, Inc. | -664 Thousand USD | -3020.361% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -1040.724% |
| International Stem Cell Corporation | -663 Thousand USD | -3025.068% |
| Bioxytran, Inc. | -3.82 Million USD | -442.367% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -39260.182% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -101764.307% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 42.869% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -1180.544% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -2715.74% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -565.998% |
| Neutra Corp. | -229.48 Thousand USD | -8928.525% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -18.132% |
| PureTech Health plc | -146.19 Million USD | 85.828% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 3.592% |
| IXICO plc | -1.43 Million USD | -1341.837% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -118.304% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 82.99% |
| CSL Limited | 3.81 Billion USD | 100.544% |
| Cellectis S.A. | -108.85 Million USD | 80.967% |